Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer
OLCMECC
A Multicenter, Prospective, Randomized Clinical Trial to Investigate Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer
1 other identifier
interventional
1,080
1 country
1
Brief Summary
Randomized, multicenter, phase III trial to compare the short and long outcomes of laparoscopic CME with open CME in treating patients with locally advanced colon cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Apr 2016
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2016
CompletedFirst Posted
Study publicly available on registry
February 15, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedJuly 6, 2016
July 1, 2016
7 years
February 4, 2016
July 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
disease-free survival
5 years
Secondary Outcomes (9)
overall survival
5 years
recurrence-free survival
5 years
local recurrence rate
5 years
length of postoperative hospital stay
30 days
early complication rate
30 days
- +4 more secondary outcomes
Study Arms (2)
Open surgery
ACTIVE COMPARATORPatients undergo open CME. A standard midline incision carefully protected is made through the abdominal wall and the abdominal cavity is explored. A colectomy with CME is performed with the removal of the afflicted colon and its accessory lymphovascular supply at their origins by resecting the colon and mesocolon in an intact envelope of visceral peritoneum and mesenteric fascia.
Laparoscopic surgery
EXPERIMENTALPatients undergo laparoscopic CME. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with carbon dioxide to allow access and visualization. The abdominal cavity is explored. A colectomy with CME is performed using laparoscopic-assisted techniques. A 6-8cm midline auxiliary incision is made for specimen extraction and anastomosis.
Interventions
A traditional midline incision is made through the abdominal wall and a colectomy with CME is performed.
3-5 small incisions are made through the abdominal wall for the placement of trocars and the abdominal cavity is insufflated with carbon dioxide to allow access, visualization and operation. A 6-8cm auxiliary incision is made for specimen extraction and anastomosis. Conversion may occur due to technical difficulties or intraoperative complications, which is defined when completion of the dissection of the mesocolon is performed through a traditional open abdominal approach. Patients undergo conversion to laparotomy will be excluded from this study.
Eligibility Criteria
You may qualify if:
- Patients suitable for curative surgery over 18 years old;
- American Society of Anesthesiologists(ASA) grade I-III;
- Pathological diagnosis of adenocarcinoma;
- Tumor located between the cecum and sigmoid colon;
- Enhanced CT scan of chest, abdominal and pelvic cavity: preoperative assessment of tumor stage is T3-T4 N0 or T any N+ (according to the National Comprehensive Cancer Network(NCCN) clinical practice guidelines in oncology: colon cancer version 2.2015);there is no distant metastasis;
- Informed consent;
- No preoperative chemoradiotherapy;
- No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.
You may not qualify if:
- Pregnant patient;
- History of psychiatric disease;
- Use of systemic steroids;
- Conversion to laparotomy;
- Simultaneous or simultaneous multiple primary colorectal cancer;
- Preoperative imaging examination results show:
- Tumor involves the surrounding organs and combined organ resection need to be done;
- distant metastasis;
- unable to perform R0 resection;
- Postoperative pathology of T1-T2 N0;
- History of any other malignant tumor in recent 5 years;
- Patients need emergency operation: mechanic ileus, perforation.
- Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The First Affiliated Hospital with Nanjing Medical Universitylead
- West China Hospitalcollaborator
- Changhai Hospitalcollaborator
- Chinese PLA General Hospitalcollaborator
- Peking Union Medical College Hospitalcollaborator
- Ruijin Hospitalcollaborator
- RenJi Hospitalcollaborator
- Shanghai Changzheng Hospitalcollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
- Fujian Medical Universitycollaborator
- First Affiliated Hospital of Chongqing Medical Universitycollaborator
Study Sites (1)
Jiangsu province hospital
Nanjing, Jiangsu, 210029, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fumin Zhang, Professor
Ethics Committee of the First Affiliated Hospital, Nanjing Medical University, Jiangsu Province Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Colorectal Surgery Department
Study Record Dates
First Submitted
February 4, 2016
First Posted
February 15, 2016
Study Start
April 1, 2016
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
July 6, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share